-
Molecular causality in the advent of foundation models
Authors:
Sebastian Lobentanzer,
Pablo Rodriguez-Mier,
Stefan Bauer,
Julio Saez-Rodriguez
Abstract:
Correlation is not causation. As simple as this widely agreed-upon statement may seem, scientifically defining causality and using it to drive our modern biomedical research is immensely challenging. In this perspective, we attempt to synergise the partly disparate fields of systems biology, causal reasoning, and machine learning, to inform future approaches in the field of systems biology and mol…
▽ More
Correlation is not causation. As simple as this widely agreed-upon statement may seem, scientifically defining causality and using it to drive our modern biomedical research is immensely challenging. In this perspective, we attempt to synergise the partly disparate fields of systems biology, causal reasoning, and machine learning, to inform future approaches in the field of systems biology and molecular networks.
△ Less
Submitted 17 January, 2024;
originally announced January 2024.
-
Drugst.One -- A plug-and-play solution for online systems medicine and network-based drug repurposing
Authors:
Andreas Maier,
Michael Hartung,
Mark Abovsky,
Klaudia Adamowicz,
Gary D. Bader,
Sylvie Baier,
David B. Blumenthal,
**g Chen,
Maria L. Elkjaer,
Carlos Garcia-Hernandez,
Mohamed Helmy,
Markus Hoffmann,
Igor Jurisica,
Max Kotlyar,
Olga Lazareva,
Hagai Levi,
Markus List,
Sebastian Lobentanzer,
Joseph Loscalzo,
Noel Malod-Dognin,
Quirin Manz,
Julian Matschinske,
Miles Mee,
Mhaned Oubounyt,
Alexander R. Pico
, et al. (14 additional authors not shown)
Abstract:
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining…
▽ More
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining capabilities. To tackle these challenges, we introduce Drugst.One, a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing. With just three lines of code, Drugst.One turns any systems biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks. Demonstrating its broad adaptability, Drugst.One has been successfully integrated with 21 computational systems medicine tools. Available at https://drugst.one, Drugst.One has significant potential for streamlining the drug discovery process, allowing researchers to focus on essential aspects of pharmaceutical treatment research.
△ Less
Submitted 4 July, 2023; v1 submitted 24 May, 2023;
originally announced May 2023.
-
A Platform for the Biomedical Application of Large Language Models
Authors:
Sebastian Lobentanzer,
Shaohong Feng,
The BioChatter Consortium,
Andreas Maier,
Cankun Wang,
Jan Baumbach,
Nils Krehl,
Qin Ma,
Julio Saez-Rodriguez
Abstract:
Current-generation Large Language Models (LLMs) have stirred enormous interest in recent months, yielding great potential for accessibility and automation, while simultaneously posing significant challenges and risk of misuse. To facilitate interfacing with LLMs in the biomedical space, while at the same time safeguarding their functionalities through sensible constraints, we propose a dedicated,…
▽ More
Current-generation Large Language Models (LLMs) have stirred enormous interest in recent months, yielding great potential for accessibility and automation, while simultaneously posing significant challenges and risk of misuse. To facilitate interfacing with LLMs in the biomedical space, while at the same time safeguarding their functionalities through sensible constraints, we propose a dedicated, open-source framework: BioChatter. Based on open-source software packages, we synergise the many functionalities that are currently develo** around LLMs, such as knowledge integration / retrieval-augmented generation, model chaining, and benchmarking, resulting in an easy-to-use and inclusive framework for application in many use cases of biomedicine. We focus on robust and user-friendly implementation, including ways to deploy privacy-preserving local open-source LLMs. We demonstrate use cases via two multi-purpose web apps (https://chat.biocypher.org), and provide documentation, support, and an open community.
△ Less
Submitted 17 February, 2024; v1 submitted 10 May, 2023;
originally announced May 2023.
-
Democratising Knowledge Representation with BioCypher
Authors:
Sebastian Lobentanzer,
Patrick Aloy,
Jan Baumbach,
Balazs Bohar,
Pornpimol Charoentong,
Katharina Danhauser,
Tunca Doğan,
Johann Dreo,
Ian Dunham,
Adrià Fernandez-Torras,
Benjamin M. Gyori,
Michael Hartung,
Charles Tapley Hoyt,
Christoph Klein,
Tamas Korcsmaros,
Andreas Maier,
Matthias Mann,
David Ochoa,
Elena Pareja-Lorente,
Ferdinand Popp,
Martin Preusse,
Niklas Probul,
Benno Schwikowski,
Bünyamin Sen,
Maximilian T. Strauss
, et al. (4 additional authors not shown)
Abstract:
Standardising the representation of biomedical knowledge among all researchers is an insurmountable task, hindering the effectiveness of many computational methods. To facilitate harmonisation and interoperability despite this fundamental challenge, we propose to standardise the framework of knowledge graph creation instead. We implement this standardisation in BioCypher, a FAIR (findable, accessi…
▽ More
Standardising the representation of biomedical knowledge among all researchers is an insurmountable task, hindering the effectiveness of many computational methods. To facilitate harmonisation and interoperability despite this fundamental challenge, we propose to standardise the framework of knowledge graph creation instead. We implement this standardisation in BioCypher, a FAIR (findable, accessible, interoperable, reusable) framework to transparently build biomedical knowledge graphs while preserving provenances of the source data. Map** the knowledge onto biomedical ontologies helps to balance the needs for harmonisation, human and machine readability, and ease of use and accessibility to non-specialist researchers. We demonstrate the usefulness of this framework on a variety of use cases, from maintenance of task-specific knowledge stores, to interoperability between biomedical domains, to on-demand building of task-specific knowledge graphs for federated learning. BioCypher (https://biocypher.org) frees up valuable developer time; we encourage further development and usage by the community.
△ Less
Submitted 17 January, 2023; v1 submitted 27 December, 2022;
originally announced December 2022.
